Home » AI cures “dumb” disease, bravely “livers” and loves oneself The first digital intelligence health industry innovation forum is about to start! _ Hyde

AI cures “dumb” disease, bravely “livers” and loves oneself The first digital intelligence health industry innovation forum is about to start! _ Hyde

by admin

Original title: AI cures “dumb” disease, bravely “liver” loves oneself, the first digital intelligence health industry innovation forum is about to start!

In the era of digital intelligence, the future “comes with”. China-Israel Hyde was born in Jerusalem, Israel in December 2019. As a witness to the development of the integration of big health and AI intelligence, it uses “artificial intelligence + real-world research + big data” to develop new drugs, moving from “digital medical” to “digital medical”. Smart medical “no man’s land!”

The dawn of a functional cure for hepatitis B is emerging. At the beginning of its establishment, the company established the goal of “smearing the liver and brain, and conquering hepatitis B”, and the no-man’s land is going through the barriers: In April 2020, the AI ​​”Thunder System” with independent intellectual property rights was built; in September, it joined the quantum computing simulation platform and cooperated with Tencent’s quantum experiment. Laboratory cooperation uses artificial intelligence to automatically generate new compounds. 17 compounds have been biologically verified, and many independently discovered compounds have excellent performance in the functional cure of hepatitis B.

With the continuous integration and development of technological innovation and “digital intelligence” in recent years, countless possibilities have become possible.

As we all know, viral hepatitis is a common infectious disease. But many people have not noticed that the heavy mental burden it brings to patients is hidden under the invisible shadow. Among them, the diagnosis rate and treatment rate of hepatitis B need to be further improved. The prejudice caused by the lack of common sense of hepatitis B disease is the fundamental source of the suffering of patients, and the resulting “stigma” is also a limitation that hinders treatment. .

See also  here is the program for the week

The founders of China-Israel Hyde are Nobel Prize winner in Chemistry, Roger Kornberg, chairman of the World Association of Top Scientists, Wang Shi, founder of Vanke Group and chairman of the Vanke School of Public Health of Tsinghua University, and Chen Mingjian, founder of Dongfang Gaosheng. Israeli scientists represented by Roger Kornberg, and Chinese scientists represented by Wei Lai, deputy dean of Beijing Tsinghua Chang Gung Memorial Hospital, supported by real-world research big data, based on the characteristics of artificial intelligence and personal biology big data, after more than a year Explore and find that customized treatment plans can be provided for patients with different genotypes, and it is expected that “digital intelligence” technology can help patients on the road to recovery, while breaking the “stigma” under silence and solving the problem of “dumb” diseases. Socialization problems.

July 28, 2021 is the eleventh World Hepatitis Day. This year, the theme of the World Health Organization’s propaganda is “Eliminate hepatitis, time does not wait.” After years of hard work, my country has greatly controlled new hepatitis infections and achieved excellent results in the control of viral hepatitis. However, according to the “Overview of the National Epidemic Situation of Notified Infectious Diseases in 2020” issued by the National Health Commission, viral hepatitis is still the Class B infectious disease with the largest number of reported cases among the legally reported infectious diseases in my country. Eliminating the harm of viral hepatitis is one of the priority tasks of my country’s medical and health care.

See also  Beach volleyball, World Cup, Rome crowns Duda-Ana Patricia and Mol-Sorum

On the occasion of “July 28 World Hepatitis Day”, China-Israel Hyde will join hands with Jingguan Media and “Economic Observer” to co-sponsor the “AI Treatment of Dumb Disease, Brave “Liver” and Love Yourself-the First Digital Intelligence Health Industry Innovation Forum”, calling on hepatitis B patients to believe in the power of technology and be brave! China-Israel Hyde will also jointly launch the “Rocket Rehabilitation Plan”-hepatitis B rehabilitation big data service package with JD Health on World Hepatitis Day, aiming to serve hepatitis B patients in the form of personalized treatment.

This forum invited experts in the field of health, famous hospitals, and top think tanks to gather in Beijing to discuss industry hotspots, interpret industry frontiers, look forward to industry trends, and create a voice for public welfare.

The forum will be held at 13:00 on July 28, on the official website of Economic Observer, Sina Weibo of Economic Observer, Sina Finance, Baidu APP, iQiyi, Youku Video, Douyin, Kuaishou, Toutiao, Zhihu, One More than 10 platforms, including Live Broadcast, ZAKER, Dangdang Social APP, and Zhongsou Souyue, conducted the entire webcast. Welcome to watch at that time!

Create in the present, science and technology for good. Let technology break this silent “dumb” disease, help every patient stay away from the shadow of hepatitis, and bravely love. We hope that all parties in the society will join hands to start the new engine of “digital intelligence”, and jointly promote the innovation and progress of the big health industry! Return to Sohu to see more

Editor:

Disclaimer: The opinions of this article only represent the author himself. Sohu is an information publishing platform. Sohu only provides information storage space services.

See also  Ghostscript: code execution vulnerability | news.de

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy